THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 126 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,801,688 | -24.9% | 556,395 | -9.9% | 0.00% | 0.0% |
| Q2 2023 | $6,391,208 | -9.1% | 617,508 | -4.7% | 0.00% | 0.0% |
| Q1 2023 | $7,031,658 | -1.5% | 648,079 | +1.8% | 0.00% | 0.0% |
| Q4 2022 | $7,140,464 | +17.7% | 636,405 | +6.4% | 0.00% | 0.0% |
| Q3 2022 | $6,067,000 | +12.5% | 598,303 | +0.5% | 0.00% | 0.0% |
| Q2 2022 | $5,393,000 | -4.2% | 595,234 | +1.0% | 0.00% | 0.0% |
| Q1 2022 | $5,631,000 | -17.0% | 589,053 | -4.1% | 0.00% | 0.0% |
| Q4 2021 | $6,788,000 | +52.2% | 614,361 | +1.9% | 0.00% | 0.0% |
| Q3 2021 | $4,459,000 | -45.2% | 602,638 | +7.4% | 0.00% | 0.0% |
| Q2 2021 | $8,144,000 | -23.2% | 560,933 | +8.0% | 0.00% | -50.0% |
| Q1 2021 | $10,598,000 | +10.7% | 519,230 | -3.6% | 0.00% | 0.0% |
| Q4 2020 | $9,573,000 | +7.3% | 538,692 | -10.8% | 0.00% | 0.0% |
| Q3 2020 | $8,925,000 | -32.9% | 603,702 | -4.7% | 0.00% | -33.3% |
| Q2 2020 | $13,295,000 | -7.5% | 633,328 | +1.8% | 0.00% | -25.0% |
| Q1 2020 | $14,378,000 | -2.8% | 622,170 | +8.9% | 0.00% | +33.3% |
| Q4 2019 | $14,798,000 | +31.5% | 571,576 | -1.1% | 0.00% | 0.0% |
| Q3 2019 | $11,253,000 | +24.5% | 577,670 | +4.3% | 0.00% | +50.0% |
| Q2 2019 | $9,041,000 | -27.5% | 553,629 | +0.6% | 0.00% | -33.3% |
| Q1 2019 | $12,471,000 | -11.5% | 550,082 | -0.1% | 0.00% | -25.0% |
| Q4 2018 | $14,095,000 | -21.1% | 550,796 | +0.8% | 0.00% | 0.0% |
| Q3 2018 | $17,855,000 | +47.1% | 546,522 | +2.1% | 0.00% | +33.3% |
| Q2 2018 | $12,140,000 | -3.1% | 535,284 | +3.6% | 0.00% | 0.0% |
| Q1 2018 | $12,526,000 | -12.3% | 516,551 | +0.9% | 0.00% | -25.0% |
| Q4 2017 | $14,282,000 | -20.7% | 512,042 | -2.7% | 0.00% | -20.0% |
| Q3 2017 | $18,020,000 | -14.7% | 526,295 | -0.7% | 0.01% | -16.7% |
| Q2 2017 | $21,117,000 | +14.8% | 530,049 | +6.1% | 0.01% | +20.0% |
| Q1 2017 | $18,388,000 | +21.8% | 499,438 | +5.5% | 0.01% | 0.0% |
| Q4 2016 | $15,097,000 | -2.0% | 473,554 | +11.4% | 0.01% | 0.0% |
| Q3 2016 | $15,403,000 | +351.7% | 424,994 | +182.9% | 0.01% | +400.0% |
| Q2 2016 | $3,410,000 | -42.1% | 150,234 | -52.0% | 0.00% | -50.0% |
| Q1 2016 | $5,890,000 | +18.1% | 313,312 | +2.9% | 0.00% | 0.0% |
| Q4 2015 | $4,989,000 | +73.2% | 304,414 | +16.2% | 0.00% | +100.0% |
| Q3 2015 | $2,880,000 | -16.9% | 262,067 | -1.5% | 0.00% | 0.0% |
| Q2 2015 | $3,464,000 | -23.4% | 266,023 | +2.0% | 0.00% | 0.0% |
| Q1 2015 | $4,524,000 | +22.3% | 260,726 | +5.2% | 0.00% | 0.0% |
| Q4 2014 | $3,698,000 | -39.6% | 247,842 | -6.7% | 0.00% | -50.0% |
| Q3 2014 | $6,121,000 | +69.3% | 265,536 | +134.2% | 0.00% | +100.0% |
| Q2 2014 | $3,615,000 | – | 113,378 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Link Fund Solutions Ltd | 5,251,349 | $135,459,000 | 69.86% |
| Chescapmanager LLC | 949,006 | $24,570,000 | 3.61% |
| Baupost Group | 9,309,168 | $241,014,000 | 2.66% |
| Rock Springs Capital Management LP | 655,200 | $16,963,000 | 0.54% |
| Rubric Capital Management LP | 173,400 | $4,489,000 | 0.51% |
| Newtyn Management, LLC | 173,300 | $4,487,000 | 0.41% |
| NJ State Employees Deferred Compensation Plan | 38,142 | $988,000 | 0.17% |
| King Wealth Management Group | 22,500 | $583,000 | 0.15% |
| Virtus ETF Advisers LLC | 29,216 | $756,000 | 0.12% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 452,615 | $11,718,000 | 0.12% |